Efficacy and Safety of Red Ginseng Concentrated Powder on Improvement of Blood Triglyceride Level
NCT ID: NCT03828188
Last Updated: 2020-05-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
50 participants
INTERVENTIONAL
2018-03-01
2019-05-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study to Evaluate the Blood Triglyceride Decreasing Effect and Safety of Korean Post-Fermented Tea Extracts
NCT04850352
Efficacy and Safety of Hydrolysed Red Ginseng Extract on Dry Eye
NCT03992287
Effect of Red Ginseng Extract on Changes in Indicators of Immune Function in Vietnamese Healthy Volunteers
NCT05480774
Efficacy Study of Korean Red Ginseng to Treat Depression
NCT01496248
Efficacy of an Extract of Concentrated Korean Red Ginseng for Preventing Upper Respiratory Tract Infections
NCT01478009
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
group A
Red Ginseng Concentrated Powder in 12 weeks → rest in 4 weeks → Placebo 12 weeks.
* Red Ginseng Concentrated Powder: 2 times daily(4.9 g/day)
* Placebo: Red Ginseng Concentrated Powder: 2 times daily(4.9 g/day)
Red Ginseng Concentrated Powder
Red Ginseng Concentrated Powder(4.9 g/day) for 12 weeks.
Placebo
Placebo for 12 weeks.
group B
Placebo 12 weeks→ rest in 4 weeks → Red Ginseng Concentrated Powder in 12 weeks.
* Red Ginseng Concentrated Powder: 2 times daily(4.9 g/day)
* Placebo: Red Ginseng Concentrated Powder: 2 times daily(4.9 g/day)
Red Ginseng Concentrated Powder
Red Ginseng Concentrated Powder(4.9 g/day) for 12 weeks.
Placebo
Placebo for 12 weeks.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Red Ginseng Concentrated Powder
Red Ginseng Concentrated Powder(4.9 g/day) for 12 weeks.
Placebo
Placebo for 12 weeks.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Those with clinically significant severe cardiovascular, endocrine, immune, respiratory, liver, biliary, renal and urinary tract, neuropsychiatry, musculoskeletal, inflammatory and hematologic and gastrointestinal disorders
* Persons with significant hypersensitivity reactions to ginseng and red ginseng
* Those with a history of gastrointestinal disorders (ex, Crohn's disease) or gastrointestinal surgery (excluding simple cecal surgery or hernia surgery) that may affect the absorption of a product for clinical trials
* Those who have received antipsychotic medication within 2 months before screening
* Those with a history of alcoholism or substance abuse
* Those who participated in other clinical trials within 2 months before screening
* Laboratory test by show the following results
* Aspartate Transaminase(AST), Alanine Transaminase(ALT) \> Reference range 3 times upper limit
* Serum Creatinine \> 2.0 mg/dL
* Pregnancy or breast feeding
* Those who doesn't accept the implementation of appropriate contraception of a childbearing woman
* Principal Investigator judged inappropriate for participation in study because of Laboratory test result, etc.
19 Years
70 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Chonbuk National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Soo-Wan Chae
Principal Investigator, Clinical Trial Center for Functional Foods
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Clinical Trial Center for Functional Foods Chonbuk National University Hospital
Jeonju, Jeollabuk-do, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
JAR-FHL-RG2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.